There's a few things that are uncomfortable about this. First maybe you haven't heard about this -
http://www.fiercebiotech.com/biotech/alzheimer-s-player-anavex-reveals-sec-probe-shares-dive
There has been a history of over publicizing around this trial. As the article states the trial has 32 people but it's not a double blind placebo controlled trial which is constantly "overlooked" in their presentation of the trial. The data analysis is underway not complete. MacFarlane speaking like this again is not really what he should be doing right now in my opinion.
There's a few things that are uncomfortable about this. First...
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $1.633K | 487.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 32189472 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 126368541 | 15 |
View Market Depth
| Last trade - 16.10pm 08/08/2024 (20 minute delay) ? |
| ATH (ASX) Chart |